78 related articles for article (PubMed ID: 19549571)
21. Enhancement of prostacyclin production in cultured bovine aortic endothelial cells by oxidized glycated low-density lipoprotein.
Kobayashi K; Watanabe J; Umeda F; Taniguchi S; Masakado M; Yamauchi T; Nawata H
Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):263-70. PubMed ID: 7784476
[TBL] [Abstract][Full Text] [Related]
22. Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S).
Jeney V; Komódi E; Nagy E; Zarjou A; Vercellotti GM; Eaton JW; Balla G; Balla J
Free Radic Biol Med; 2009 Mar; 46(5):616-23. PubMed ID: 19100829
[TBL] [Abstract][Full Text] [Related]
23. Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-density-lipoprotein peroxidation.
Mazière C; Dantin F; Conte MA; Degonville J; Ali D; Dubois F; Mazière JC
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):57-62. PubMed ID: 9806884
[TBL] [Abstract][Full Text] [Related]
24. Effect of curcumin on down-expression of thrombospondin-4 induced by oxidized low-density lipoprotein in mouse macrophages.
Zhou ZY; Chen YQ; Wang FY; Tian N; Fan CL
Biomed Mater Eng; 2014; 24(1):181-9. PubMed ID: 24211897
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cells prevent accumulation of lipid hydroperoxides in low-density lipoprotein.
Smalley DM; Hogg N; Kalyanaraman B; Pritchard KA
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3469-74. PubMed ID: 9437194
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human low density lipoprotein oxidation by active principles from spices.
Naidu KA; Thippeswamy NB
Mol Cell Biochem; 2002 Jan; 229(1-2):19-23. PubMed ID: 11936843
[TBL] [Abstract][Full Text] [Related]
27. Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification.
Safari MR; Sheikh N
Prostaglandins Leukot Essent Fatty Acids; 2003 Jul; 69(1):73-7. PubMed ID: 12878454
[TBL] [Abstract][Full Text] [Related]
28. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
Verhoye E; Langlois MR;
Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
[TBL] [Abstract][Full Text] [Related]
29. 5-methyltetrahydrofolic acid stimulates endothelin-1 production in low density lipoprotein-treated human endothelial cells.
Ronco AM; Llanos M; Tamayo D; Hirsch S
Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):188-94. PubMed ID: 17367704
[TBL] [Abstract][Full Text] [Related]
30. Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets.
Mahfouz MM; Kummerow FA
Prostaglandins Other Lipid Mediat; 1998 Jul; 56(4):197-217. PubMed ID: 9777653
[TBL] [Abstract][Full Text] [Related]
31. Correlation between oxidation of low density lipoproteins and prostacyclin synthesis in cultured smooth muscle cells.
Ek B; Humble L
Biochem Pharmacol; 1991 Mar; 41(5):695-9. PubMed ID: 1900157
[TBL] [Abstract][Full Text] [Related]
32. Dynamic AFM detection of the oxidation-induced changes in size, stiffness, and stickiness of low-density lipoprotein.
Wang K; Li Y; Luo C; Chen Y
J Nanobiotechnology; 2020 Nov; 18(1):167. PubMed ID: 33183326
[TBL] [Abstract][Full Text] [Related]
33. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease.
Mosca L; Rubenfire M; Tarshis T; Tsai A; Pearson T
Am J Cardiol; 1997 Oct; 80(7):825-30. PubMed ID: 9381992
[TBL] [Abstract][Full Text] [Related]
34. Oxidized low-density lipoprotein and atherosclerosis.
Steinberg D; Witztum JL
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2311-6. PubMed ID: 21084697
[No Abstract] [Full Text] [Related]
35. Estradiol 17beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees.
Zhu X; Bonet B; Knopp RH
Atherosclerosis; 2000 Jan; 148(1):31-41. PubMed ID: 10580168
[TBL] [Abstract][Full Text] [Related]
36. Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL.
Alomar Y; Nègre-Salvayre A; Levade T; Valdiguié P; Salvayre R
Biochim Biophys Acta; 1992 Oct; 1128(2-3):163-6. PubMed ID: 1420286
[TBL] [Abstract][Full Text] [Related]
37. Discrimination between minimally modified LDL and fully oxidized LDL using monoclonal antibodies.
Lowhalidanon K; Khunkaewla P
Anal Biochem; 2021 Apr; 619():114103. PubMed ID: 33453163
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation.
Chang PY; Lu SC; Su TC; Chou SF; Huang WH; Morrisett JD; Chen CH; Liau CS; Lee YT
J Lipid Res; 2004 Nov; 45(11):2116-22. PubMed ID: 15314101
[TBL] [Abstract][Full Text] [Related]
39. Antioxidant potentials of furanodihydrobenzoxanthones from Artocarpus elasticus and their protection against oxLDL induced injury in SH-SY5Y cells.
Baiseitova A; Shah AB; Khan AM; Idrees M; Kim JH; Lee YH; Kong IK; Park KH
Biomed Pharmacother; 2023 Sep; 165():115278. PubMed ID: 37536031
[TBL] [Abstract][Full Text] [Related]
40. Toxic reactions of oxidized LDL on cells of acute myeloid leukemia.
Vahrenwald F; Galka K; Jürgens G; Bruchelt G; Girgert R; Schweizer P
Leuk Res; 1997; 21(11-12):1071-6. PubMed ID: 9444941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]